Joshua A Kazam
Director · 1 filing · Latest: Jun 18, 2026
Allogene Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALLO | Joshua A Kazam | Director | Jun 18, 2026 | Option Exercise | $0.00 | 47,700 | — | 398,463 |